Skip Navigation



Cerebral Cortex Advance Access published online on September 11, 2008

Cerebral Cortex, doi:10.1093/cercor/bhn159
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
19/7/1515    most recent
bhn159v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Curia, G.
Right arrow Articles by Avoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curia, G.
Right arrow Articles by Avoli, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Downregulation of Tonic GABAergic Inhibition in a Mouse Model of Fragile X Syndrome

Giulia Curia1, Thomas Papouin1,2, Philippe Séguéla1 and Massimo Avoli1,3

1 Montreal Neurological Institute and Department of Neurology and Neurosurgery, McGill University, Montreal, Canada H3A 2B4, 2 Department of Biology, Ecole Normale Superieure, 75005, Paris, France, 3 Department of Experimental Medicine, Sapienza Università di Roma, 00100, Rome, Italy

Address correspondence to Massimo Avoli, MD, PhD, 3801 University Street, Room 794, Montreal, Quebec H3A 2B4, Canada. Email: massimo.avoli{at}mcgill.ca.

The absence of fragile X mental retardation protein results in the fragile X syndrome (FXS), a common form of mental retardation associated with attention deficit, autistic behavior, and epileptic seizures. The phenotype of FXS is reproduced in fragile X mental retardation 1 (fmr1) knockout (KO) mice that have region-specific altered expression of some {gamma}-aminobutyric acid (GABAA) receptor subunits. However, little is known about the characteristics of GABAergic inhibition in the subiculum of these animals. We employed patch-clamp recordings from subicular pyramidal cells in an in vitro slice preparation. In addition, semiquantitative polymerase chain reaction and western blot experiments were performed on subiculum obtained from wild-type (WT) and KO mice. We found that tonic GABAA currents were downregulated in fmr1 KO compared with WT neurons, whereas no significant differences were observed in phasic GABAA currents. Molecular biology analysis revealed that the tonic GABAA receptor subunits {alpha}5 and {delta} were underexpressed in the fmr1 KO mouse subiculum compared with WT. Because the subiculum plays a role in both cognitive functions and epileptic disorders, we propose that altered tonic inhibition in this structure contributes to the behavioral deficits and epileptic activity seen in FXS patients. This conclusion is in line with evidence implicating tonic GABAA inhibition in learning and memory.

Key Words: fragile X • GABA • patch-clamp • subiculum • tonic inhibition


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
D. Belelli, N. L. Harrison, J. Maguire, R. L. Macdonald, M. C. Walker, and D. W. Cope
Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function
J. Neurosci., October 14, 2009; 29(41): 12757 - 12763.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. K. K. Pacey, S. P. Heximer, and D. R. Hampson
Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic Seizures
Mol. Pharmacol., July 1, 2009; 76(1): 18 - 24.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.